American Journal of Ophthalmology

Copyright permission has been granted for the OHTS to reproduce this document.
Visit the American Journal of Ophthalmology web site

Piltz J, Gross, R, Shin DH, Beiser JA, Dorr DA, Kass MA, Gordon MO and the OHTS Study Group. Contralateral effect of topical ß-adrenergic antagonists in initial one-eyed trials in the Ocular Hypertension Treatment Study. Am J Ophthalmol 130:441-453, 2000.


Controlled Clinical Trials

Copyright permission has been granted for the OHTS to reproduce these documents.
Single copies of these articles may be downloaded and printed for personal research and study.

Visit the Controlled Clinical Trials web site

Wong, KF, Achtenberg, JF, Gordon, MO, and the Ocular Hypertension Treatment Study(OHTS) Group: Automated Forms Processing: Trials, Tribulations and Triumphs. Controlled Clinical Trials 15:3S, p. 76S, 1994.

Wong, KF, Gordon, MO, Achtenberg, JF, and the Ocular Hypertension Treatment Study (OHTS) Group: Electronic Document Archival for a Data Coordinating Center. Controlled Clinical Trials 16:3S, p. 38S, 1995.

Gordon, MO, Schechtman, KB, Li, Z, Kass, MA, and the Ocular Hypertension Treatment Study (OHTS) Group: A Protocol to Minimize Bias and Regression to the Mean in Measurement of Intraocular Pressure. Controlled Clinical Trials 16:3S, p.98S, 1995.

Wong K, Gordon, MO, and the Ocular Hypertension Treatment Study (OHTS) Group: An inexpensive electronic system for handling adverse event reports. Controlled Clin Trial 17:2S, 1996.

Wong K, Gordon MO, and the Ocular Hypertension Treatment Study (OHTS) Group: Automatic forms processing with Windows 95: Hyperbole? Controlled Clin Trial 17:2S, 1996.

Wong K, Gordon MO, and the Ocular Hypertension Treatment Study (OHTS) Group: Electronic systems for handling adverse event reports.  Controlled Clin Trial 18(3S):145S, 1997.

Morris PA, Wilder AK, Gordon MO and the Ocular Hypertension Treatment Study (OHTS) Group: Site visit strategies to increase collaboration of the clinic, resource centers and coordinating center. Controlled Clin Trials 19(3S):51S, 1998.

Dorr DA, Gordon MO and the Ocular Hypertension Treatment Study (OHTS) Group: A simple graphical method for displaying multiple dimensions by group over time:  an example using the SF-36. Controlled Clin Trials 19(3S):72S, 1998.

Fischbach E, Achtenberg J, Clark K, Tourville D, Gordon MO and the Ocular Hypertension Treatment Study (OHTS) Group: (Under) Estimating paper storage requirements for a multicenter clinical trial. Controlled Clin Trials 19(3S):84S, 1998.

Bednarski MA, Achtenberg J and the Ocular Hypertension Treatment Study (OHTS) Group: Delivering coordinating center reports to clinics via the world wide web. Controlled Clin Trials 20(2S):60S, 1999.

Wilder AK, Morris PA, Gordon MO and the Ocular Hypertension Treatment Study (OHTS)Group: Offering continuation education credits at clinic coordinating meeting. Controlled Clin Trials 20(2S):67S, 1999.

Morris PA, Wilder AK, Bednarski MA, Gordon MO and the Ocular Hypertension Treatment Study (OHTS) Group: Accessing SAS reports by the central coordinators via the world wide web.  Controlled Clin Trials  20(2S):68S, 1999.

Long E, Dunn D, Gordon M, Ocular Hypertension Treatment Study (OHTS) Group. A publications and presentation policy for a multicenter clinical trial. Control Clin Trials: 21(2S):77S, 2000.

Randant D, Long E, Gordon M, the Ocular Hypertension Treatment Study (OHTS) Group. Handling forms in a multicenter clinical trial.  Control Clin Trials 21(2S):100S, 2000. Bednarski MA, Beiser JA, Gordon MA, Morris PA, Wilder AK, and the Ocular Hypertension Study (OHTS) Group. Providing performance reports to clinics via the world wide web.  Control Clin Trials 22(2S): 80S, 2001. [click here for poster]

Morris PA, Wilder AK, Bednarski M, Gordon MO, and the Ocular Hypertension Treatment Study Group. Omnibus clinic tracking report. Control Clin Trials 22(2S):  83S, 2001.

Wilder AK, Morris PA, Gordon MO and the Ocular Hypertension Treatment Study (OHTS ) Group. Improving timeliness of annual IRB approvals. Control Clin Trials 22(2S): 79S, 2001.

Achtenberg J, Hornbeck E, Gordon M and the Ocular Hypertension Treatment Study (OHTS) Group. Enhanced documentation of case report forms. Control Clin Trials 24(3S):180S, 2003.

Bednarski M, Achtenberg J, Gordon M, and the Ocular Hypertension Treatment Study Group (OHTS). Tracking and reporting multi-stage processes in a clinical trial. 24(S): 187S, 2003. 

Kymes S, Gordon M, and the Ocular Hypertension Treatment Study Group (OHTS). Economic evaluation in randomized clinical trials – a promise half met? 24(3S): 187S, 2003.

Morris P, Wilder A, Gordon M, and the Ocular Hypertension Treatment Study Group (OHTS). Encouraging participation after protocol change. Control Clin Trials 24(S):214S, 2003.


Midwest Sas User Group

Bednarski MA, Achtenberg J,  the Ocular Hypertension Treatment Study (OHTS) Group and the Collaborative Longitudinal Evaluation of Keratoconus Study (CLEK). A Quick and Dirty Method for Delivering SAS ® Reports Via the World Wide Web. Proceedings of the 1998 Midwest SAS Users Group Conference: 405-410, 1998.


OPHTHALMOLOGY

Copyright permission has been granted for the OHTS to reproduce these documents.
Single copies of these articles may be downloaded and printed for personal research and study.

Visit the Ophthalmology Home Page at Elsevier Science or Science DirectBrandt JD, Beiser JA, Gordon MO, Kass MA and the OHTS Group.  Central Corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology 108:1779-1788, 2001.


Sas Users Group International

Dorr D, Gordon MO, and the Ocular Hypertension Treatment Study (OHTS) Group: Graphically conquering the SF-36: A tool for illustrating subscale by group over time using SAS/GRAPH® Software. Proceedings of the twenty-third Annual SAS Users Group International Conference: 856-859, 1998.